AU Patent

AU2017250267A1 — Compositions for topical application of compounds

Assigned to Illustris Pharmaceuticals Inc · Expires 2018-11-08 · 8y expired

What this patent protects

Compositions for transdermal delivery of an active agent and methods for using such compositions are described herein.

USPTO Abstract

Compositions for transdermal delivery of an active agent and methods for using such compositions are described herein.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2017250267A1
Jurisdiction: AU
Classification: —
Expires: 2018-11-08
Drug substance claim: No
Drug product claim: No
Assignee: Illustris Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.